Market Analysis
Product Positioning
Competitor Monitoring
Find Global Buyers
Find Contact Information
Company Comparison
Supply Chain Optimization
Email Marketing
Customer Management
Blog
FAQs
About Topease
Agency Program
CameroonSun Pharmaceutical Industries Limited (Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Founded in 1983 by Dilip Shanghvi, it is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Sun Pharma is a leading global specialty generic company with global revenue of US$ 6.2 billion, supported by 41 manufacturing facilities providing high-quality medicines to more than 100 countries. Its portfolio spans generics, branded generics, specialty and complex products, over-the-counter (OTC) medicines, antiretrovirals, active pharmaceutical ingredients (APIs), and intermediates across therapeutic areas including neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, and respiratory. The company employs over 43,000 people globally and invests 6-8% of annual revenues into research and development.
| Import | Export |
|---|---|
|
Trade Records
8
|
Trade Records
13
|
|
Suppliers
1
|
Buyers
2
|
|
Latest Import Date
2026-05
|
Latest Export Date
2026-06
|
According to Topease's global trade data, SUN PHARMACEUTICAL INDUSTRIES LTD exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the SUN PHARMACEUTICAL INDUSTRIES LTD distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, SUN PHARMACEUTICAL INDUSTRIES LTD sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore SUN PHARMACEUTICAL INDUSTRIES LTD's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUN PHARMACEUTICAL INDUSTRIES LTD | 3003 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into SUN PHARMACEUTICAL INDUSTRIES LTD's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| CENAME | SUN PHARMACEUTICAL INDUSTRIES LTD | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUN PHARMACEUTICAL INDUSTRIES LTD | 3003 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore SUN PHARMACEUTICAL INDUSTRIES LTD's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access SUN PHARMACEUTICAL INDUSTRIES LTD's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.